News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Actavis (ACT) Announces 42% Increase to $2.01 in Second Quarter 2013 Non-GAAP Earnings Per Share



7/25/2013 7:12:28 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARSIPPANY, N.J., July 25, 2013 — /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today reported net revenue increased 46.8 percent to $1.99 billion for the second quarter 2013, compared to $1.36 billion in the second quarter 2012. On a non-GAAP basis, diluted earnings per share for the second quarter 2013 were $2.01, compared to $1.42 per diluted share in the second quarter 2012, an increase of 41.5 percent.

Help employers find you! Check out all the jobs and post your resume.

Read at The Herald


comments powered by Disqus
Actavis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES